Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Salivary Gland Neoplasms × pazopanib × Clear all

Sponsor

Conditions

Carcinoma, Renal Cell 22 Sarcoma 17 Neoplasms 8 Breast Neoplasms 8 Neoplasm Metastasis 7 Ovarian Neoplasms 6 Carcinoma, Non-Small-Cell Lung 6 Hemangiosarcoma 5 Fallopian Tube Neoplasms 5 Lung Neoplasms 4 Liposarcoma 4 Leiomyosarcoma 4 Kidney Neoplasms 4 Urinary Bladder Neoplasms 3 Sarcoma, Synovial 3 Neurofibrosarcoma 3 Histiocytoma, Malignant Fibrous 3 Sarcoma, Alveolar Soft Part 2 Recurrence 2 Prostatic Neoplasms 2 Pancreatic Neoplasms 2 Neuroendocrine Tumors 2 Melanoma 2 Gliosarcoma 2 Glioblastoma 2 Fibrosarcoma 2 Clear-cell metastatic renal cell carcinoma 2 Chondrosarcoma, Extraskeletal Myxoid 2 Carcinoma, Ovarian Epithelial 2 Brain Neoplasms 2

Interventions

Cetuximab 3 Vorinostat 2 Radiosurgery 2 Nivolumab 2 Ipilimumab 2 Dasatinib 2 Cisplatin 2 Bevacizumab 2 temsirolimus 1 pembrolizumab 1 ispinesib 1 eribulin 1 dehydroftorafur 1 apalutamide 1 alectinib 1 Sorafenib 1 Sirolimus 1 Platinum 1 Pilocarpine 1 Oral Hygiene 1 N-(3-chloro-4-((3-fluorobenzyl)oxy)phenyl-6-(5-((methylsulfonyl)ethyl)aminomethyl)-2-furyl)-4-quinazolinamine 1 Moxibustion 1 Magnetic Resonance Spectroscopy 1 MK 2206 1 Lapatinib 1 Irinotecan 1 Immunoglobulin G 1 Gonadotropin-Releasing Hormone 1 Gemcitabine 1 Gefitinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡